Raggae

Ask VT AI
View News Summary
  • Manchester City set to sign Wolves' Rayan Ait-Nouri for around £50 million, as they seek to resolve their left-back issue.
  • DOJ mandates Keysight to divest Spirent units to preserve competition in critical testing markets.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News
Ask VT AI
View News Summary
  • Manchester City set to sign Wolves' Rayan Ait-Nouri for around £50 million, as they seek to resolve their left-back issue.
  • DOJ mandates Keysight to divest Spirent units to preserve competition in critical testing markets.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Raggae